FDA Inspection 1098996 — Chongqing Carelife Pharmaceutical Co., Ltd.

Chongqing Carelife Pharmaceutical Co., Ltd. — FEI 3011903543

The FDA completed an inspection of Chongqing Carelife Pharmaceutical Co., Ltd. on July 19, 2019 in Chongqing. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 19, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chongqing (China)